Nearly 70% of people with diabetes believe there is stigma associated with their condition, according to a survey from Abbott ...

Abbott’s ABT diversified business portfolio is well-positioned to drive continued momentum in 2024. The stock carries a Zacks ...

Investors feel optimistic about Abbott's robust strength in the EPD, Diabetes and Nutrition businesses. However, unfavorable forex impacts are concerning.

We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other best ...

Abbott, Dexcom, Insulet, Medtronic and others are developing next-gen sensors, pumps and algorithms for type 2 diabetes ...

Abbott’s continuous glucose monitoring (CGM ... Beyond the US market, Glooko and Danish digital therapeutics company Hedia ...

For individuals with type 1 diabetes, low-glucose alerts improve the time below range for drivers and reduce the incidence of ...

Glooko announced today that its platform now supports the Abbott FreeStyle Libre continuous glucose monitoring (CGM) in the U ...

Abbott Laboratories is undervalued by the market, despite its strong fundamentals and strategic moves in high-growth areas like diabetes care and weight-loss treatments. The company boasts a high ...